STOCK TITAN

IQVIA (IQV) SVP granted 18,634 stock appreciation rights

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IQVIA Holdings executive Michael J. Fedock received a new equity award. On February 9, 2026, he was granted a stock appreciation right covering 18,634 shares of IQVIA common stock at an exercise price of $192.67 per share, expiring on February 9, 2036.

The stock appreciation right was acquired as a grant and is held directly. According to the terms, it will vest in three annual installments beginning on February 9, 2027, aligning the senior vice president of FP&A’s compensation with long-term shareholder value.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fedock Michael J.

(Last) (First) (Middle)
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD

(Street)
DURHAM NC 27703

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right $192.67 02/09/2026 A 18,634 (1) 02/09/2036 Common Stock 18,634 $0 18,634 D
Explanation of Responses:
1. This stock appreciation right vests in three annual installments beginning on February 9, 2027.
Remarks:
SVP, FP&A
/s/ Matthew Gilmartin, Attorney-in Fact for Michael J. Fedock 02/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity award did IQVIA (IQV) executive Michael J. Fedock receive?

Michael J. Fedock received a stock appreciation right covering 18,634 IQVIA common shares. The award gives value based on future stock price gains above the $192.67 exercise price, aligning his compensation with company performance over time.

When was Michael J. Fedock’s new IQVIA (IQV) stock appreciation right granted?

The stock appreciation right was granted on February 9, 2026. This grant date starts the award’s life, which runs until its February 9, 2036 expiration, and precedes the scheduled vesting that begins in 2027 under the award’s terms.

How does Michael J. Fedock’s IQVIA (IQV) stock appreciation right vest?

The stock appreciation right vests in three annual installments beginning on February 9, 2027. This means portions of the 18,634-share award become exercisable over three years, supporting long-term retention and performance incentives for the executive recipient.

What is the exercise price and term of the IQVIA (IQV) stock appreciation right granted?

The stock appreciation right has an exercise price of $192.67 per share and expires on February 9, 2036. Value is realized only if IQVIA’s share price exceeds $192.67 before that expiration, encouraging focus on long-term stock price growth.

How many derivative securities does Michael J. Fedock hold after this IQVIA (IQV) grant?

Following the reported transaction, Michael J. Fedock beneficially owns 18,634 derivative securities represented by the stock appreciation right. This figure reflects the full size of the February 9, 2026 award held directly after the grant acquisition.
Iqvia Hldgs Inc

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Latest SEC Filings

IQV Stock Data

30.05B
168.60M
1.05%
102.1%
2.9%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
DURHAM